Overview

Preemptive Strike With Bortezomib in Multiple Myeloma Patients

Status:
Terminated
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
To evaluate whether using the drug bortezomib at the start of remission will prevent relapse for a longer period of time.
Phase:
Phase 3
Details
Lead Sponsor:
University of Arkansas
Treatments:
Bortezomib